Dr. Psihogios' research program is centered on improving health outcomes for adolescents and young adults (AYA) with cancer and other chronic medical conditions by targeting a modifiable health behavior — treatment nonadherence. Her research studies use state-of-the-art mobile health approaches to learn how to deliver adherence support in the moment and context that AYA need it the most, and how this information can be leveraged for personalized interventions.

Toward this goal, in 2019, Dr. Psihogios received a Mentored Clinical Scientist Research Career Development Award (K08) from the National Cancer Institute to translate ecological momentary assessment data into a just-in-time adaptive intervention for promoting oral chemotherapy adherence in AYA with leukemia.

For over 10 years, Dr. Psihogios has worked as a research assistant, interventionist, research coordinator, and PI on numerous NIH, CDC, and foundation-funded research projects – all related to the health and adjustment of children, adolescents, and young adults with chronic health conditions.

In 2017, the American Cancer Society awarded her a postdoctoral grant to conduct a formative, mixed methods study of facilitators and barriers to AYA cancer treatment adherence. In 2018, the Mattie Miracle Cancer Foundation awarded Dr. Psihogios a pilot grant to test the feasibility and acceptability of using a hospital-based text messaging service to assess daily oral chemotherapy adherence in AYA with leukemia.

Among her notable career accomplishments, Dr. Psihogios:

• Received the Distinguished Research Trainee Award (Postdoctoral Fellow Category) from the Research Institute at Children's Hospital of Philadelphia
• Leads a NIH-funded study to develop the first just-in-time adaptive intervention for promoting oral chemotherapy adherence among AYA with acute lymphoblastic leukemia
• Co-founded and co-chairs the Society of Pediatric Psychology Digital Health Special Interest Group (American Psychological Association, Division 54)